CULTURE METHOD, EVALUATION METHOD AND STORAGE METHOD FOR CANCER-TISSUE-DERIVED CELL MASS OR AGGREGATED CANCER CELL MASS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jan 10, 2013
app pub date -
Jan 19, 2011
filing date -
Jan 19, 2010
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
It is intended to provide a method for culturing a novel cancer tissue-derived cell mass or a novel aggregated cancer cell mass that can reflect the behavior of cancer cells accurately in vivo. First, a cancer tissue-derived cell mass or an aggregated cancer cell mass is prepared from an individual. The novel cancer tissue-derived cell mass or the novel aggregated cancer cell mass is cultured, and the properties are evaluated using the cultured cell mass. Examples of the evaluation of properties include the evaluation of genes and the evaluation of culture conditions. In addition, the cancer tissue-derived cell mass or the aggregated cancer cell mass can be stored. It is possible to establish an optimal therapeutic method for an individual efficiently by linking the clinical information or the genetic information on the individual to the stored cancer tissue-derived cell mass or the stored aggregated cancer cell mass.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully